Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot?
Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?
And here is our regular feature in which we highlight a different person each week. This time around, we note that True North Therapeutics hired Pamela Wapnick as chief financial officer. Previously, she was vice president of finance for research and development at Amgen, where she responsible for corporate finance for global R&D.
Chronos Therapeutics hired Timothy Schulz-Utermoehl as vice president, preclinical development;
Chronos Therapeutics hired Fraser Murray as vice president, preclinical development;
Johnson & Johnson hired Marc Liebowitz as head of health technology strategy and business development;
Inovio Pharmaceuticals promoted Ami Shah Brown as vice president, regulatory affairs;
Cipla hired Kedar Upadhye as global chief financial officer;
Cempra hired John Bluth as executive vice president, investor relations and corporate communications;
Galmed Pharmaceuticals hired Dr. Ran Oren as chief medical officer;
Sigma-Tau Pharmaceuticals named Michael Minarich as chief executive officer;
Parexel named David Godwin as senior vice president, global business development;
Parexel named Michelle Graham as senior vice president and chief human resources officer;
Parexel named Dr. Sy Pretorius as senior vice president and chief scientific officer;
Parexel named Joshua Schultz as senior vice president, worldwide head of access;
Inspyr Therapeutics hired Christopher Lowe as chief executive officer and president;
Accera hired C. Evan Ballantyne as chief financial officer;
M-Pharmaceutical hired Gary Thompson to head its US subsidiary;
ESSA Pharma hired Peter Virsik as executive vice president and chief operating officer.
About the Author Reprints
